Valuation Metrics and Recent Changes
Aarti Surfactants currently trades at ₹410.15, down from the previous close of ₹460.05, marking a significant intraday drop. The stock’s 52-week range spans from ₹317.65 to ₹651.00, indicating considerable volatility over the past year. The company’s P/E ratio stands at 27.92, a figure that has contributed to the recent shift in valuation grade from 'very attractive' to 'attractive'. This P/E is moderate when compared to its peers within the Specialty Chemicals industry, where companies like Titan Biotech and Sanstar exhibit P/E ratios of 70.18 and 92.43 respectively, categorised as 'very expensive'.
Similarly, the price-to-book value (P/BV) ratio of Aarti Surfactants is 1.41, which remains reasonable and supports the 'attractive' valuation status. This contrasts with some competitors such as Platinum Industrials, which trades at a higher P/BV of 33.17, reflecting a more expensive valuation. The enterprise value to EBITDA (EV/EBITDA) ratio of 9.29 further underscores the company’s relatively fair valuation compared to peers like Stallion India, which has an EV/EBITDA of 35.34.
Financial Performance and Returns Analysis
Despite the valuation adjustment, Aarti Surfactants’ financial performance metrics present a mixed picture. The company’s return on capital employed (ROCE) is 8.70%, while return on equity (ROE) is a modest 5.04%. These returns are below the levels typically favoured by growth-oriented investors but are not uncommon for a micro-cap entity navigating competitive pressures in the specialty chemicals space.
Examining stock returns relative to the Sensex reveals that Aarti Surfactants has outperformed the benchmark year-to-date with a 5.53% gain against the Sensex’s negative 10.80%. However, over longer horizons, the stock has underperformed significantly, with a three-year return of -36.72% compared to the Sensex’s 22.79%, and a five-year return of -72.13% versus the Sensex’s 54.62%. This underperformance highlights the challenges the company faces in delivering sustained shareholder value.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Comparative Industry Valuation Context
Within the Specialty Chemicals sector, Aarti Surfactants’ valuation stands out as relatively moderate. While the company’s P/E of 27.92 is higher than some 'very attractive' peers like TGV Sraac (P/E 9.35) and Gulshan Polyols (P/E 28.09 but with a much lower EV/EBITDA of 12.19), it remains significantly lower than the 'very expensive' segment, which includes Sanstar and Titan Biotech. This positioning suggests that while the stock is no longer at a bargain basement valuation, it still offers a more reasonable entry point than many sector counterparts.
The PEG ratio of 11.19, however, is notably elevated, indicating that the stock’s price growth may not be fully supported by earnings growth expectations. This contrasts sharply with peers such as Gulshan Polyols (PEG 0.13) and TGV Sraac (PEG 0.10), which exhibit more favourable growth-to-price ratios. The elevated PEG ratio may be a factor in the downgrade from 'Hold' to 'Sell' in the company’s Mojo Grade, which currently stands at 34.0.
Market Capitalisation and Risk Considerations
Aarti Surfactants is classified as a micro-cap stock, which inherently carries higher volatility and liquidity risk. The recent 10.85% single-day decline underscores this vulnerability. Investors should weigh these risks against the company’s valuation and growth prospects. The dividend yield of 0.25% is minimal, offering little income cushion amid price fluctuations.
Given the company’s financial metrics and market performance, the downgrade in Mojo Grade from 'Hold' to 'Sell' on 8 April 2026 reflects a cautious stance by analysts. The valuation grade shift from 'very attractive' to 'attractive' signals that while the stock remains reasonably priced relative to earnings and book value, the margin of safety has narrowed.
Aarti Surfactants Ltd or something better? Our SwitchER feature analyzes this micro-cap Specialty Chemicals stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Investor Takeaways and Outlook
For investors considering Aarti Surfactants, the current valuation presents a nuanced opportunity. The stock’s P/E and P/BV ratios suggest it is attractively priced relative to many peers, yet the elevated PEG ratio and modest returns on capital caution against overly optimistic expectations. The company’s underperformance over medium to long-term horizons relative to the Sensex further emphasises the need for careful scrutiny.
Given the micro-cap status and recent price volatility, risk-averse investors may prefer to monitor the stock for signs of stabilisation or improvement in earnings growth before committing capital. Conversely, value-oriented investors with a higher risk tolerance might view the current 'attractive' valuation as a potential entry point, particularly if the company can demonstrate operational improvements and better capital efficiency in upcoming quarters.
In summary, Aarti Surfactants Ltd’s shift in valuation grade reflects evolving market dynamics and company fundamentals. While no longer a 'very attractive' bargain, it remains a noteworthy contender within the Specialty Chemicals sector, warranting close attention from investors seeking exposure to this niche industry.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
